[Multimorbidity in liver surgery]

Emrullah Birgin1, Jan Heil2, Elisabeth Miller2

  • 1Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Deutschland. emrullah.birgin@uniklinik-ulm.de.

PubMed

Insights

Multimorbid patients face higher risks after liver resection, especially with open procedures and certain liver conditions. Minimally invasive surgery and enhanced recovery protocols can significantly improve outcomes.

Area of Science:

  • Hepatobiliary surgery
  • Geriatric medicine
  • Chronic disease management

Context:

  • Multimorbidity, defined as 3+ chronic diseases, affects over 50% of patients over 60.
  • The Charlson Comorbidity Index (CCI) assesses multimorbidity severity and its impact on surgical outcomes.
  • Liver resection patients often present with complex comorbidities.

Purpose:

  • To evaluate the impact of multimorbidity on postoperative outcomes following liver resection.
  • To identify specific risk factors and protective strategies for multimorbid patients undergoing liver surgery.

Summary:

  • Multimorbid patients have increased morbidity and mortality risks post-liver resection, primarily due to liver failure.
  • Open liver resection with biliary reconstruction, especially for primary liver tumors associated with metabolic associated fatty liver disease (MAFLD), poses a significant risk.
  • Minimally invasive resection, liver preconditioning, and enhanced recovery after surgery (ERAS) protocols demonstrably reduce postoperative complications.

Impact:

  • Highlights the elevated risks associated with multimorbidity in liver surgery.
  • Emphasizes the benefits of minimally invasive approaches and standardized perioperative care.
  • Informs surgical decision-making and patient management strategies for complex liver resection cases.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
429
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
116